Studies from Research Institute for Complex Issues of Cardiovascular Diseases Describe New Findings in Antihyperlipidemic Agents (Atorvastatin Can Modulate DNA Damage Repair in Endothelial Cells Exposed to Mitomycin C).

Předmět:
Zdroj: Cardiovascular Week; 4/25/2023, p690-690, 1p
Abstrakt: Angiology, Antibiotics, Antihyperlipidemic Agents, Antineoplastics, Atorvastatin Therapy, DNA Damage, DNA Research, Deoxyribonucleic Acid, Drugs and Therapies, Endothelial Cells, Genetics, Health and Medicine, Mitomycin Therapy, Mitomycins, Pharmaceuticals, Proteomics, Indolequinones Keywords: Angiology; Antibiotics; Antihyperlipidemic Agents; Antineoplastics; Atorvastatin Therapy; DNA Damage; DNA Research; Deoxyribonucleic Acid; Drugs and Therapies; Endothelial Cells; Genetics; Health and Medicine; Indolequinones; Mitomycin Therapy; Mitomycins; Pharmaceuticals; Proteomics EN Angiology Antibiotics Antihyperlipidemic Agents Antineoplastics Atorvastatin Therapy DNA Damage DNA Research Deoxyribonucleic Acid Drugs and Therapies Endothelial Cells Genetics Health and Medicine Indolequinones Mitomycin Therapy Mitomycins Pharmaceuticals Proteomics 690 690 1 04/24/23 20230425 NES 230425 2023 APR 24 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- Investigators publish new report on antihyperlipidemic agents. [Extracted from the article]
Databáze: Complementary Index